Saudi Chemical Co.

Saudi Chemical Co. (2230) is a leading pharmaceutical and chemical manufacturing company based in Saudi Arabia. It specializes in the production of generic drugs, medical supplies, and industrial chemicals. The company operates through two main segments: Pharmaceuticals, which includes the manufacturing and distribution of generic medicines, and Chemicals, which produces industrial chemicals and solvents. Saudi Chemical also engages in contract manufacturing for international pharmaceutical firms.

Revenue is generated primarily from the sale of pharmaceutical products to hospitals, pharmacies, and government healthcare institutions. The Chemicals segment contributes through sales to industrial clients. The company's revenue is diversified across both segments, with pharmaceuticals being the larger contributor. Recent quarterly revenues have ranged from 1.68B SAR to 1.79B SAR, reflecting stable demand.

Saudi Chemical operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It competes with other regional generic drug manufacturers and international players. The company holds a strong position in the Saudi market, benefiting from government healthcare spending and local manufacturing incentives. Its market cap of 7.13B SAR and PE of 21.65 indicate moderate valuation relative to earnings.

Its primary customers are hospitals, clinics, pharmacies, and government health agencies in Saudi Arabia. The company also exports to neighboring Gulf countries. The target audience includes both public and private healthcare providers. With a focus on generic drugs, it serves a broad patient population seeking affordable medications. The Saudi market remains its core geographic focus, supported by government initiatives to localize pharmaceutical production.

An auto-generated descriptive profile based on company data, for informational purposes only.